The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. ARS Pharmaceuticals Inc shares valued at $928,005 were sold by Tanimoto Sarina on Apr 16 ’24. At $9.28 per share, Tanimoto Sarina sold 100,000 shares. The insider’s holdings dropped to 1,647,447 shares worth approximately $13.9 million following the completion of this transaction.
Also, Lowenthal Richard E sold 100,000 shares, netting a total of over 928,005 in proceeds. Following the sale of shares at $9.28 each, the insider now holds 1,647,447 shares.
Before that, Tanimoto Sarina had sold 100,000 shares from its account. In a trade valued at $927,735, the CHIEF MEDICAL OFFICER traded ARS Pharmaceuticals Inc shares for $9.28 each. Upon closing the transaction, the insider’s holdings decreased to 100,000 shares, worth approximately $13.9 million.
As published in a research note from Leerink Partners on March 05, 2024, ARS Pharmaceuticals Inc [SPRY] has been rated up from a Market perform to an Outperform and the price target has been revised to $18 from $6. Analysts at William Blair upgraded the stock from ‘”a Mkt perform”‘ to ‘”an Outperform”‘ outlook in a report released in mid February. As of September 20, 2023, William Blair has decreased its “an Outperform” rating to a “Mkt perform” for SPRY. Earlier on January 31, 2023, Wedbush initiated its rating. Their recommendation was “an Outperform” for SPRY stock.
Analyzing SPRY Stock Performance
During the last five days, there has been a drop of approximately -8.66%. Over the course of the year, ARS Pharmaceuticals Inc shares have jumped approximately 54.01%. Shares of the company reached a 52-week high of $11.27 on 03/28/24 and a 52-week low of $5.19 on 01/04/24. A 50-day SMA is recorded $8.64, while a 200-day SMA reached $6.34. Nevertheless, trading volume fell to 0.92 million shares from 0.48 million shares the previous day.
Support And Resistance Levels for ARS Pharmaceuticals Inc (SPRY)
According to the 24-hour chart, there is a support level at 8.15, which, if violated, would cause prices to drop to 7.86. In the upper region, resistance lies at 8.96. The next price resistance is at 9.48. RSI (Relative Strength Index) is 41.03 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.41, which suggests the price will decrease in the coming days. Percent R is at 96.74%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
